BALANCE SHEET DETAILS
|3 Months Ended|
Mar. 31, 2023
|Condensed Financial Information Disclosure [Abstract]|
|BALANCE SHEET DETAILS||BALANCE SHEET DETAILS
Inventory as of March 31, 2023 and December 31, 2022 was comprised of the following (in thousands):
During the three months ended March 31, 2022, the Company recorded additions to the inventory provision of $0.1 million. Additions to the inventory provision for the three months ended March 31, 2023 were immaterial.
Intangible assets consisted of in-process research and development with an indefinite life of $0.3 million as of March 31, 2023 and December 31, 2022. No indicators of impairment were identified during the three months ended March 31, 2023.
Accrued expenses as of March 31, 2023 and December 31, 2022 were as follows (in thousands):
No definition available.
The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef